Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -23,800 | -11,400 | -11,950 | -4,440 | N/A |
| Depreciation Amortization | 1,340 | 510 | 350 | 420 | N/A |
| Other Working Capital | 3,740 | -2,890 | -80 | 1,240 | N/A |
| Other Operating Activity | 210 | -3,250 | 860 | -680 | 0 |
| Operating Cash Flow | $-18,510 | $-17,030 | $-10,820 | $-3,460 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,270 | -2,010 | -150 | -860 | N/A |
| Other Investing Activity | 21,490 | -30,400 | 13,220 | 4,270 | 0 |
| Investing Cash Flow | $14,220 | $-32,410 | $13,070 | $3,410 | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -500 | -500 | -500 | -420 | N/A |
| Other Financing Activity | 493 | 54,580 | 100 | 430 | 0 |
| Financing Cash Flow | $-7 | $54,080 | $-400 | $10 | $N/A |
| Beginning Cash Position | 8,380 | 3,750 | 1,910 | 1,940 | N/A |
| End Cash Position | 4,090 | 8,380 | 3,750 | 1,910 | N/A |
| Net Cash Flow | $-4,290 | $4,630 | $1,840 | $-30 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,510 | -17,030 | -10,820 | -3,460 | N/A |
| Free Cash Flow | -18,510 | -17,030 | -10,820 | -3,460 | 0 |